Top Markets
#1 Akedo Akedo +63.33%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.58%
#4 Cross Cross +34.01%
#5 Black Phoenix Black Phoenix +33.94%
#6 Cap Cap +32.66%
#7 Velvet Velvet +25.73%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.06%
#9 Ravencoin Ravencoin +13.84%
#10 DoubleZero DoubleZero +13.55%
Coin of the day
Akedo Akedo
設定
言語
日本
通貨
USD
テーマ
Valion Bio, Inc. Valion Bio, Inc.

Valion Bio, Inc.

VBIO
株式のランク #38911
Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead... Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
株価
$0.1645
時価総額
$681.26K
変化（1日）
-3.69%
変化（1年）
-95.30%
国
US
取引 Valion Bio, Inc. (VBIO)

カテゴリー

Healthcare
Valion Bio, Inc.（VBIO）の株価履歴
終値の最高値: $0.24 （2026-08-01）

終値の最安値: $7.60K （2021-11-01）
Valion Bio, Inc. の株価履歴（2021 ～ 2026）
年間株価パフォーマンス
年 パフォーマンス
2026 (TTM) -21.26%
2025 -56.71%
2024 -86.09%
2023 -97.85%
2022 -79.33%
2021 0.00%
類似企業または競合の株価
企業 株価 変化率 1年% 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.40 29.49%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $842.41 29.12%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $726.49 6.37%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.46 11.09%
BE